TrialEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences2025

Population pharmacokinetic and exposure-response study of a novel anti-tuberculosis drug to inform its dosage design in phase III clinical trial.

Weijie Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.